Skip to content

Korean Medicine for Periodontal Disease

A preliminary study to evaluate patient outcomes, feasibility, preliminary effectiveness, safety and economic evaluation of Korean medicine treatment for periodontal disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011609
Enrollment
45
Registered
2026-02-12
Start date
2025-09-24
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Acupuncture treatment, Herbal mouthwash) : 1) Acupuncture Group Intervention: Electroacupuncture treatment Acupoints: ST7 (Xiaguan), ST6 (Jiache), LI4 (Hegu), with optional additional acupoints
gargle for approximately 30 seconds and then spit out Treatment period: 4 weeks 3) Control Group Intervention: Oral hygiene education and standard self-care management

Sponsors

Dongguk University Ilsan Oriental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Male and female participants aged 20 years or older and under 65 years. (2) Individuals diagnosed with gingivitis or mild periodontitis. (3) Individuals who have voluntarily provided written informed consent to participate in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with severe or advanced periodontitis. (2) Individuals who have received scaling or preventive periodontal treatment within 3 months prior to the date of informed consent. (3) Current smokers. (4) Individuals wearing orthodontic appliances. (5) Individuals with pathological lesions of the oral soft tissues requiring evaluation or treatment by other medical or dental specialties. (6) Individuals who require immediate treatment for dental caries. (7) Individuals with uncontrolled chronic diseases, including diabetes mellitus, liver disease, cardiovascular disease, renal disease, or bleeding disorders. (8) Individuals requiring treatment for clinically significant immune disorders, infectious diseases, malignancies, or psychiatric disorders. (9) Individuals currently taking medications known to affect periodontal disease, such as nifedipine, phenytoin, or cyclosporine. (10) Individuals who have taken antibiotics within the past 4 weeks, are currently taking antibiotics, or are scheduled to receive antibiotic therapy during the study period. (11) Individuals who have received investigational drugs or investigational medical devices within 30 days prior to study participation. (12) Pregnant or breastfeeding women, or women of childbearing potential who are not using an acceptable method of contraception. (13) Individuals who are deemed inappropriate for participation in the study by the principal investigator or study staff for any other reason.

Design outcomes

Primary

MeasureTime frame
Study feasibility test

Secondary

MeasureTime frame
Probing Depth, Bleeding on Probing, Gingival index, Plaque index;Visual analog scale;Salivary biomarkers (IL-1ß, IL-6, TNF-a, MMPs, and TIMP-1);Quality of Life Questionnaire (EQ-5D-5L);Subgingival microbiome

Countries

Korea, Republic of

Contacts

Public ContactKyungsun Han

Dongguk University Ilsan Oriental Hospital

khan@dumc.or.kr+82-31-961-9111

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 14, 2026